Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H37ClN2O2 |
| Molecular Weight | 421.016 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C1CCCCC1)C(=O)C(C)(C)C2(O)CCN(CCC3=C(Cl)C=CC=C3)CC2
InChI
InChIKey=CNIMNQJXZKALLC-UHFFFAOYSA-N
InChI=1S/C24H37ClN2O2/c1-23(2,22(28)26(3)20-10-5-4-6-11-20)24(29)14-17-27(18-15-24)16-13-19-9-7-8-12-21(19)25/h7-9,12,20,29H,4-6,10-11,13-18H2,1-3H3
| Molecular Formula | C24H37ClN2O2 |
| Molecular Weight | 421.016 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Pipradimadol is a 4.4-disubstituted piperidine derivative which demonstrates, in animal experiments, effects typical for certain antidepressant and antiserotonin drugs. Pipradimadol is the central serotonin antagonist. Pipradimadol exhibits antinociceptive properties also. Behavioral tests reflect overall sedation after pipradimadol, decreased rectal temperature and locomotor activity; cataleptic effects of tetrabenazine are antagonized and noradrenaline as well as dopamine reuptake in vitro are slightly inhibited. Homovanillic acid, a metabolite of dopamine is strongly increased after pipradimadol in rat striatum. Pipradimadol was used as analgesic agent.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6181982
200 mg was taken nightly for 6 nights
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:06:30 GMT 2025
by
admin
on
Mon Mar 31 18:06:30 GMT 2025
|
| Record UNII |
CBI6614BOL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C267
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C66405
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
CBI6614BOL
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
68797-29-5
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
DTXSID90988505
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
100000082217
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
68883
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
CHEMBL148635
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
SUB09882MIG
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY | |||
|
4680
Created by
admin on Mon Mar 31 18:06:30 GMT 2025 , Edited by admin on Mon Mar 31 18:06:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |